130 related articles for article (PubMed ID: 37217415)
1. High-dose-rate brachytherapy for airway malignancy a single institution experience.
Siddiqui Z; Falkson C; Hopman W; Mahmud A
Brachytherapy; 2023; 22(4):542-546. PubMed ID: 37217415
[TBL] [Abstract][Full Text] [Related]
2. High-dose-rate brachytherapy in symptom palliation due to malignant endobronchial obstruction: a quantitative assessment.
de Aquino Gorayeb MM; Gregório MG; de Oliveira EQ; Aisen S; Carvalho Hde A
Brachytherapy; 2013; 12(5):471-8. PubMed ID: 23541114
[TBL] [Abstract][Full Text] [Related]
3. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer.
Chang LF; Horvath J; Peyton W; Ling SS
Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):589-96. PubMed ID: 7509330
[TBL] [Abstract][Full Text] [Related]
4. Primary radiotherapy with endobronchial high-dose-rate brachytherapy boost for inoperable lung cancer: long-term results.
Rochet N; Hauswald H; Stoiber EM; Hensley FW; Becker HD; Debus J; Lindel K
Tumori; 2013; 99(2):183-90. PubMed ID: 23748812
[TBL] [Abstract][Full Text] [Related]
5. High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer.
Anacak Y; Mogulkoc N; Ozkok S; Goksel T; Haydaroglu A; Bayindir U
Lung Cancer; 2001 Nov; 34(2):253-9. PubMed ID: 11679184
[TBL] [Abstract][Full Text] [Related]
6. A prospective analysis of high-dose-rate endobronchial brachytherapy in the palliation of obstructive symptoms in lung cancer patients: A single-institution experience.
Goldberg M; Timotin E; Farrell T; Puksa S; Donde B; Sur R
Brachytherapy; 2015; 14(5):655-61. PubMed ID: 25983031
[TBL] [Abstract][Full Text] [Related]
7. Salvage treatment with sole high-dose-rate endobronchial interventional radiotherapy (brachytherapy) for isolated endobronchial tumor recurrence in non-small-cell lung cancer patients: a 20-year experience.
Soror T; Kovács G; Fürschke V; Ismail M; Badakhshi H
Brachytherapy; 2019; 18(5):727-732. PubMed ID: 31227399
[TBL] [Abstract][Full Text] [Related]
8. Endobronchial brachytherapy for metastasis from extrapulmonary malignancies as an effective treatment for palliation of symptoms.
Donovan E; Timotin E; Farrell T; Donde B; Puksa S; Sur R
Brachytherapy; 2017; 16(3):630-638. PubMed ID: 28202343
[TBL] [Abstract][Full Text] [Related]
9. The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer: a systematic review.
Ung YC; Yu E; Falkson C; Haynes AE; Stys-Norman D; Evans WK;
Brachytherapy; 2006; 5(3):189-202. PubMed ID: 16864071
[TBL] [Abstract][Full Text] [Related]
10. Endobronchial brachytherapy in the management of lung malignancies: 20 years of experience in an Australian center.
Knox MC; Bece A; Bucci J; Moses J; Graham PH
Brachytherapy; 2018; 17(6):973-980. PubMed ID: 30064904
[TBL] [Abstract][Full Text] [Related]
11. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.
Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y
Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780
[TBL] [Abstract][Full Text] [Related]
12. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer.
Kubaszewska M; Skowronek J; Chicheł A; Kanikowski M
Neoplasma; 2008; 55(3):239-45. PubMed ID: 18348661
[TBL] [Abstract][Full Text] [Related]
13. Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension.
Gejerman G; Mullokandov EA; Bagiella E; Blaivas A; Beitler JJ
Brachytherapy; 2002; 1(4):204-10. PubMed ID: 15062168
[TBL] [Abstract][Full Text] [Related]
14. High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic malignancies.
Gustafson G; Vicini F; Freedman L; Johnston E; Edmundson G; Sherman S; Pursel S; Komic M; Chen P; Borrego JC
Cancer; 1995 May; 75(9):2345-50. PubMed ID: 7712446
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for late toxicity after endobronchial brachytherapy: a multivariate analysis.
Hennequin C; Tredaniel J; Chevret S; Durdux C; Dray M; Manoux D; Perret M; Bonnaud G; Homasson JP; Chotin G; Hirsch A; Maylin C
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):21-7. PubMed ID: 9747815
[TBL] [Abstract][Full Text] [Related]
16. Out-patient high-dose-rate endobronchial brachytherapy for palliation of lung cancer: an observational study.
Scarda A; Confalonieri M; Baghiris C; Binato S; Mazzarotto R; Palamidese A; Zuin R; Fantoni U
Monaldi Arch Chest Dis; 2007 Sep; 67(3):128-34. PubMed ID: 18018751
[TBL] [Abstract][Full Text] [Related]
17. Endobronchial brachytherapy in the treatment of malignant lung tumours.
Escobar-Sacristán JA; Granda-Orive JI; Gutiérrez Jiménez T; Delgado JM; Rodero Baños A; Saez Valls R
Eur Respir J; 2004 Sep; 24(3):348-52. PubMed ID: 15358689
[TBL] [Abstract][Full Text] [Related]
18. Treatment of recurrent bronchial carcinoma: the role of high-dose-rate endoluminal brachytherapy.
Hauswald H; Stoiber E; Rochet N; Lindel K; Grehn C; Becker HD; Debus J; Harms W
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):373-7. PubMed ID: 19836162
[TBL] [Abstract][Full Text] [Related]
19. High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.
Celebioglu B; Gurkan OU; Erdogan S; Savas I; Köse K; Kurtman C; Gonullu U
Jpn J Clin Oncol; 2002 Nov; 32(11):443-8. PubMed ID: 12499415
[TBL] [Abstract][Full Text] [Related]
20. Palliative endobronchial brachytherapy for non-small cell lung cancer.
Reveiz L; Rueda JR; Cardona AF
Cochrane Database Syst Rev; 2012 Dec; 12():CD004284. PubMed ID: 23235606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
